Healthcare >> CEO Interviews >> March 18, 2015
Christopher G. Clement is President and Chief Executive Officer of DARA BioSciences, Inc. Mr. Clement was the Co-Founder of Oncogenerix, Inc., a privately held specialty biopharmaceutical company focused on the in-licensing of oral liquid formulations and oncology-support therapeutics, which was acquired by DARA. He was former President and CEO of Savient Pharmaceuticals Inc. when he refocused the company to be a specialty pharmaceutical company that resulted in a $1 billion market valuation. Mr. Clement also was the former Chairman and CEO of Epicyte Pharmaceutical, and was the Executive VP, Senior VP and Chief Marketing Officer at Ares-Serono Group. Further, he has held a number of senior management positions at Searle Pharmaceuticals LLC. Mr. Clement completed his B.A. in marketing and business at Mercy College. Profile
Mr. Clement: DARA BioSciences is a specialty pharmaceutical company with a unique focus in the area of oncology and supportive care. It
